Article

Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans

Department of Biological Sciences, University of Alabama, Tuscaloosa, Alabama, United States
The Journal of Neuroscience : The Official Journal of the Society for Neuroscience (Impact Factor: 6.75). 05/2005; 25(15):3801-12. DOI: 10.1523/JNEUROSCI.5157-04.2005
Source: PubMed

ABSTRACT Parkinson's disease (PD) is linked genetically to proteins that function in the management of cellular stress resulting from protein misfolding and oxidative damage. Overexpression or mutation of alpha-synuclein results in the formation of Lewy bodies and neurodegeneration of dopaminergic (DA) neurons. Human torsinA, mutations in which cause another movement disorder termed early-onset torsion dystonia, is highly expressed in DA neurons and is also a component of Lewy bodies. Previous work has established torsins as having molecular chaperone activity. Thus, we examined the ability of torsinA to manage cellular stress within DA neurons of the nematode Caenorhabditis elegans. Worm DA neurons undergo a reproducible pattern of neurodegeneration after treatment with 6-hydroxydopamine (6-OHDA), a neurotoxin commonly used to model PD. Overexpression of torsins in C. elegans DA neurons results in dramatic suppression of neurodegeneration after 6-OHDA treatment. In contrast, expression of either dystonia-associated mutant torsinA or combined overexpression of wild-type and mutant torsinA yielded greatly diminished neuroprotection against 6-OHDA. We further demonstrated that torsins seem to protect DA neurons from 6-OHDA through downregulating protein levels of the dopamine transporter (DAT-1) in vivo. Additionally, we determined that torsins protect robustly against DA neurodegeneration caused by overexpression of alpha-synuclein. Using mutant nematodes lacking DAT-1 function, we also showed that torsin neuroprotection from alpha-synuclein-induced degeneration occurs in a manner independent of this transporter. Together, these data have mechanistic implications for movement disorders, because our results demonstrate that torsin proteins have the capacity to manage sources of cellular stress within DA neurons.

0 Followers
 · 
89 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract As our society ages, neurodegenerative disorders like Parkinson`s disease (PD) are increasing in pandemic proportions. While mechanistic understanding of PD is advancing, a treatment with well tolerable drugs is still elusive. Here, we show that administration of the naturally occurring polyamine spermidine, which declines continuously during aging in various species, alleviates a series of PD-related degenerative processes in the fruit fly Drosophila melanogaster and the nematode Caenorhabditis elegans, two established model systems for PD pathology. In the fruit fly, simple feeding with spermidine inhibited loss of climbing activity and early organismal death upon heterologous expression of human α-synuclein, which is thought to be the principal toxic trigger of PD. In this line, administration of spermidine rescued α-synuclein-induced loss of dopaminergic neurons, a hallmark of PD, in nematodes. Alleviation of PD-related neurodegeneration by spermidine was accompanied by induction of autophagy, suggesting that this cytoprotective process may be responsible for the beneficial effects of spermidine administration.
    Cell cycle (Georgetown, Tex.) 10/2014; 13(24). DOI:10.4161/15384101.2014.973309 · 5.01 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Parkinson's disease (PD) is the second most common neurodegenerative disorder in the elderly people, currently with no cure. Its mechanisms are not well understood, thus studies targeting cause-directed therapy or prevention are needed. This study uses the transgenic Caenorhabditis elegans PD model. We demonstrated that dietary supplementation of the worms with an extract from the cultivated red seaweed Chondrus crispus decreased the accumulation of α-synulein and protected the worms from the neuronal toxin-, 6-OHDA, induced dopaminergic neurodegeneration. These effects were associated with a corrected slowness of movement. We also showed that the enhancement of oxidative stress tolerance and an up-regulation of the stress response genes, sod-3 and skn-1, may have served as the molecular mechanism for the C. crispus-extract-mediated protection against PD pathology. Altogether, apart from its potential as a functional food, the tested red seaweed, C. crispus, might find promising pharmaceutical applications for the development of potential novel anti-neurodegenerative drugs for humans.
    Marine Drugs 04/2015; 13(4):2250-66. DOI:10.3390/md13042250 · 3.51 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Dystonia is a movement disorder characterized by sustained or intermittent muscle contraction causing abnormal, often repetitive, movements, postures, or both. Cervical dystonia (CD) affects the musculature of the neck in a focal way or associated to other parts of the body. CD is the most common form of dystonia. The present study objectives to obtain clinical and genetic information of patients with CD. Eighty-eight patients with CD were recruited in Botulinum Toxin Clinic and Movement Disorders Clinic of Hospital de Clinicas of the Federal University of Paraná (HC-UFPR) between May of 2008 and August of 2009. They were submitted the clinical, laboratorial, neuro-imaging and genetic evaluation. DNA was extracted from periferic blood and submitted at analysis to DYT1 and DYT6 mutations by PCR according to standard protocols. The male:female ratio was 1:1.75. The average ages at onset for focal dystonia (41.05±16.87 years) and for segmental dystonia (35±23.14 years) were larger than generalized dystonia (12.36±9.10 years). There was a direct decreased of incidence of generalized dystonia with the age. Twenty-three patients had cases of CD in the family. In these cases there were more prevalence of generalized dystonia than focal dystonia (ratio 2.2:1), in opposition of sporadic cases (ratio 1:1.83). The focal dystonia in patients with familiar history of dystonia was less severe and less painful than sporadic cases (p<0.05). The generalized sporadic cases complained less painful than familiar generalized cases. Two patients, with familiar and generalized dystonia beginning in legs with 6 and 12 years old, had c.907GAGdel mutation on DYT6 gene. Three patients had the unprecedent c.289 (p.Gln97X) DYT6 gene nonsense mutation. One of them had no familiar history of dystonia. This patient started his symptoms by arms at 22 years old, and he had secondary generalization. The other two patients were from the same family. The first opened the symptoms at 18 years old by right arm keeping segmental dystonia (cranial-cervical and arms). The second had the c.506G>A (p.Arg169Gln) missense mutation plus. She has started the symptoms at 6 years old and sprayed the dystonia for generalizations associated with speech disorders. These findings are in line with the low penetrance and great phenotypic variability related in DYT6 patients, independent of mutation found. Regarding the association with other movement disorders, DYT1 and DYT6 mutations were not found in four patients with myoclonic movements and in three patients with Parkinsonism. We can state, in agreement with previous studies, that analysis for DYT1 mutations in patients with cervical dystonia should be performed in patients with generalized and familiar dystonia. The DYT6 analysis can be performed in patients with cervical dystonia regardless the distribution or the familiar history.
    11/2013, Degree: Ph.D., Supervisor: Helio Afonso Ghizoni Teive

Full-text

Download
34 Downloads
Available from
May 27, 2014